MedX Health Corp (MDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MedX Health Corp (MDX) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-687.65K) by net assets (CA$-10.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MedX Health Corp - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how MedX Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MedX Health Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedX Health Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Phio Pharmaceuticals Corp
NASDAQ:PHIO
|
-0.212x |
|
Greenridge Exploration Inc.
F:HW3
|
0.000x |
|
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
|
-0.291x |
|
Spirent Communications plc
LSE:SPT
|
0.039x |
|
JOY SPREADER GROUP INC.
F:5YN
|
N/A |
|
SENSEONICS HLGS.INC.-001
F:6L6
|
N/A |
|
Vistry Group PLC
LSE:VTY
|
0.059x |
|
Solstice Gold Corp
V:SGC
|
-0.525x |
Annual Cash Flow Conversion Efficiency for MedX Health Corp (2013–2024)
The table below shows the annual cash flow conversion efficiency of MedX Health Corp from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-8.52 Million | CA$-2.51 Million | 0.295x | -38.53% |
| 2023-12-31 | CA$-7.14 Million | CA$-3.42 Million | 0.479x | +21.14% |
| 2022-12-31 | CA$-7.08 Million | CA$-2.80 Million | 0.396x | -68.21% |
| 2021-12-31 | CA$-3.63 Million | CA$-4.52 Million | 1.244x | -11.46% |
| 2020-12-31 | CA$-2.07 Million | CA$-2.91 Million | 1.405x | +204.09% |
| 2019-12-31 | CA$-2.87 Million | CA$-1.32 Million | 0.462x | -72.62% |
| 2018-12-31 | CA$-1.54 Million | CA$-2.61 Million | 1.688x | +72.37% |
| 2017-12-31 | CA$-1.50 Million | CA$-1.47 Million | 0.979x | +34.25% |
| 2016-12-31 | CA$-1.83 Million | CA$-1.33 Million | 0.729x | +225.13% |
| 2015-12-31 | CA$-2.39 Million | CA$-536.53K | 0.224x | -41.31% |
| 2014-12-31 | CA$-2.26 Million | CA$-864.08K | 0.382x | +814.58% |
| 2013-12-31 | CA$-3.40 Million | CA$-141.94K | 0.042x | -- |
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more